Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 110-52-1
2. Tetramethylene Dibromide
3. Butane, 1,4-dibromo-
4. 1,4-butylene Bromide
5. Tetramethylene Bromide
6. 1,4-dibrombutan
7. 1,4-dibromo-butane
8. 1.4-dibromobutane
9. G49phr6jfu
10. Dbb
11. Nsc-71435
12. Tetramethylenebromide
13. 1,4-dibrombutan [german]
14. Alpha,omega-dibromobutane
15. Ccris 8917
16. Einecs 203-775-5
17. Unii-g49phr6jfu
18. Nsc 71435
19. Brn 1071199
20. Ai3-14617
21. 1,4dibromobutane
22. 1,4-dibrombutane
23. 1,4-dibromobutan
24. 1,4 Dibromobutane
25. Butane,4-dibromo-
26. Mfcd00000261
27. 1, 4-dibromobutane
28. 1,4 -dibromobutane
29. 1,4-dibromo Butane
30. Dibromo-1,4 Butane
31. 1, 4-dibromo-butane
32. 1,4-dibromo-n-butane
33. Brch2ch2ch2ch2br
34. 1,4-bis(bromanyl)butane
35. Schembl8484
36. Wln: E4e
37. 1,4-dibromobutane, 99%
38. Dsstox_cid_24364
39. Dsstox_rid_80172
40. Nciopen2_003230
41. Dsstox_gsid_44364
42. 4-01-00-00267 (beilstein Handbook Reference)
43. Dibromobutane, 1,4-
44. 1,4-dibromobutane-[13c4]
45. Chembl3185714
46. Dtxsid5044364
47. Nsc71435
48. Zinc1696823
49. Tox21_301070
50. Bbl027293
51. Stl280306
52. Akos000118763
53. Cs-w020631
54. Ncgc00248278-01
55. Ncgc00254971-01
56. Bp-21423
57. Cas-110-52-1
58. Am20080049
59. D0176
60. Ft-0606854
61. D77910
62. A802208
63. Q161522
64. Q-200082
65. F1908-0120
| Molecular Weight | 215.91 g/mol |
|---|---|
| Molecular Formula | C4H8Br2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 3 |
| Exact Mass | 215.89723 g/mol |
| Monoisotopic Mass | 213.89928 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Complexity | 17.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
78
PharmaCompass offers a list of 1,4-Dibromobutane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 1,4-Dibromobutane manufacturer or 1,4-Dibromobutane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 1,4-Dibromobutane manufacturer or 1,4-Dibromobutane supplier.
PharmaCompass also assists you with knowing the 1,4-Dibromobutane API Price utilized in the formulation of products. 1,4-Dibromobutane API Price is not always fixed or binding as the 1,4-Dibromobutane Price is obtained through a variety of data sources. The 1,4-Dibromobutane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tox21_301070 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_301070, including repackagers and relabelers. The FDA regulates Tox21_301070 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_301070 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tox21_301070 supplier is an individual or a company that provides Tox21_301070 active pharmaceutical ingredient (API) or Tox21_301070 finished formulations upon request. The Tox21_301070 suppliers may include Tox21_301070 API manufacturers, exporters, distributors and traders.
Tox21_301070 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tox21_301070 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tox21_301070 GMP manufacturer or Tox21_301070 GMP API supplier for your needs.
A Tox21_301070 CoA (Certificate of Analysis) is a formal document that attests to Tox21_301070's compliance with Tox21_301070 specifications and serves as a tool for batch-level quality control.
Tox21_301070 CoA mostly includes findings from lab analyses of a specific batch. For each Tox21_301070 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tox21_301070 may be tested according to a variety of international standards, such as European Pharmacopoeia (Tox21_301070 EP), Tox21_301070 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tox21_301070 USP).
